I’ve reported previously about my experiences with insulin timings, including what happens when we go off-label and blend Humalog U100 with Lyumjev U100. I’ve now done another phase of experimentation, with a new data point. And some analysis of why these results might come about. I’ll first rewind a bit and explain that Humalog / …
I’ve written numerous times about modelling the activity profiles of various insulins. Telling my oref-based Automated Insulin Delivery (AID) system which insulin I’m using lets it model the current situation (and forecast the future) quite well. We usually think about this in terms of the simple concept of a single bolus: how quickly it starts …
Different insulins have effect (and get used up) at different speeds, and modelling this is important for accurate calculation of subsequent insulin doses. Some automated insulin delivery (AID) systems try to determine this themselves (e.g. CamAPS has nowhere for us to tell it which insulin we’re using) and some (e.g. Medtronic and Control-IQ) seem to …
I have recently made some changes in my oref1-based AID/loop system which have dramatically improved the behaviour with Lyumjev. And it seemed those changes may also apply to Humalog, so it was time to test it out. Insulin models This is not about some fancy new algorithm, it’s just about optimising the insulin activity profile …
For years I used Humalog as my “fast” insulin (before that I used Actrapid!) so when I moved to Fiasp that’s what I had to compare with. I’ve recently experimented with switching back to Humalog to check my settings, and the results were interesting. Including that my no-bolus, no-announce closed-loop system still worked. I have …
People who know me wouldn’t be surprised to hear I’ve been experimenting with an insulin change recently. I started out pumping using Humalog. In 2018 I spent a few months experimenting with Apidra in the hope I could get a faster result (and thus a more-responsive loop). And then when Fiasp finally arrived in Australia …